Brazil Emergency Use Pathways for Medical Devices and IVDs

As of September 15th, ANVISA has terminated all emergency use pathways. 

Stay informed about special access routes in response to COVID-19

Emergo by UL consultants are monitoring the development of expedited regulatory routes in medical device markets worldwide. The situation is changing daily, and we encourage you to create a free RAMS account, where you can access real-time updates on COVID-19 regulatory developments from our international research team.